Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study.
<h4>Aim</h4>To investigate the clinical efficacy of population-based treatment of human papillomavirus (HPV) infections with Paiteling.<h4>Methods</h4>Between 1 June 2024 and 31 August 2024, 575 HPV-infected patients attending The First People's Hospital of Jingzhou gyne...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315376 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555415150624768 |
|---|---|
| author | Na He Lin Song Zhaoxia Lu Qingsong Zeng Wumei Jin Wenrong He Cunjian Yi |
| author_facet | Na He Lin Song Zhaoxia Lu Qingsong Zeng Wumei Jin Wenrong He Cunjian Yi |
| author_sort | Na He |
| collection | DOAJ |
| description | <h4>Aim</h4>To investigate the clinical efficacy of population-based treatment of human papillomavirus (HPV) infections with Paiteling.<h4>Methods</h4>Between 1 June 2024 and 31 August 2024, 575 HPV-infected patients attending The First People's Hospital of Jingzhou gynecology outpatient clinic from October 2020 to December 2023 were retrospectively collected, all of whom were analyzed for HPV subtype infection and the presence or absence of cytomorphological abnormality using HPV-DNA testing and TCT; they were divided into 319 cases in the Paiteling group and 256 cases in the Interferon group, and the patients of both groups were subjected to TCT 1 month after the end of the administration of the medication and HPV review.<h4>Results</h4>1. The three most frequent subtypes of HPV in this data are HPV 16, HPV 52, and HPV 58, all of which are high-risk types; 2. The results of the post-treatment review of HPV infection showed that the overall effective rate of the Paiteling group was better than that of the Interferon group, and the difference in the cumulative effective rate between the two groups was statistically significant (P < 0.001); 3. Comparative analysis of patients with 14 high-risk types of human papillomavirus in a single infection showed that the overall conversion rate in the Paiteling group was 76.3%, higher than that of the Interferon group, which was 36.7%. The difference was statistically significant (P < 0.001).<h4>Conclusion</h4>The overall efficacy of Paiteling for cervical HPV infection is significantly better than that of Interferon, and it is worth promoting its use in the clinic. |
| format | Article |
| id | doaj-art-c7fd974f79aa455cbeca90bcc751454a |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-c7fd974f79aa455cbeca90bcc751454a2025-01-08T05:33:28ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031537610.1371/journal.pone.0315376Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study.Na HeLin SongZhaoxia LuQingsong ZengWumei JinWenrong HeCunjian Yi<h4>Aim</h4>To investigate the clinical efficacy of population-based treatment of human papillomavirus (HPV) infections with Paiteling.<h4>Methods</h4>Between 1 June 2024 and 31 August 2024, 575 HPV-infected patients attending The First People's Hospital of Jingzhou gynecology outpatient clinic from October 2020 to December 2023 were retrospectively collected, all of whom were analyzed for HPV subtype infection and the presence or absence of cytomorphological abnormality using HPV-DNA testing and TCT; they were divided into 319 cases in the Paiteling group and 256 cases in the Interferon group, and the patients of both groups were subjected to TCT 1 month after the end of the administration of the medication and HPV review.<h4>Results</h4>1. The three most frequent subtypes of HPV in this data are HPV 16, HPV 52, and HPV 58, all of which are high-risk types; 2. The results of the post-treatment review of HPV infection showed that the overall effective rate of the Paiteling group was better than that of the Interferon group, and the difference in the cumulative effective rate between the two groups was statistically significant (P < 0.001); 3. Comparative analysis of patients with 14 high-risk types of human papillomavirus in a single infection showed that the overall conversion rate in the Paiteling group was 76.3%, higher than that of the Interferon group, which was 36.7%. The difference was statistically significant (P < 0.001).<h4>Conclusion</h4>The overall efficacy of Paiteling for cervical HPV infection is significantly better than that of Interferon, and it is worth promoting its use in the clinic.https://doi.org/10.1371/journal.pone.0315376 |
| spellingShingle | Na He Lin Song Zhaoxia Lu Qingsong Zeng Wumei Jin Wenrong He Cunjian Yi Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. PLoS ONE |
| title | Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. |
| title_full | Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. |
| title_fullStr | Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. |
| title_full_unstemmed | Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. |
| title_short | Clinical efficacy analysis of the Chinese medicine Paiteling applied to human papillomavirus infection: A retrospective study. |
| title_sort | clinical efficacy analysis of the chinese medicine paiteling applied to human papillomavirus infection a retrospective study |
| url | https://doi.org/10.1371/journal.pone.0315376 |
| work_keys_str_mv | AT nahe clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT linsong clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT zhaoxialu clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT qingsongzeng clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT wumeijin clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT wenronghe clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy AT cunjianyi clinicalefficacyanalysisofthechinesemedicinepaitelingappliedtohumanpapillomavirusinfectionaretrospectivestudy |